The role of cytopathology in the diagnosis, management, and follow-up of patients with gynecologic neoplasms has expanded tremendously since the introduction of the Papanicolaou test, more than 50 years ago. Evidently, advances in HPV testing have revolutionized cervical cancer screening, which now faces new challenges in the setting of increasingly available HPV vaccines. In addition, recent changes in gynecologic tumor nomenclature and staging of gynecologic neoplasms have introduced challenges specific to cytopathology, which if not taken into consideration, might lead to incorrect diagnoses, confusion on the part of the patients and their clinical teams, and potentially suboptimal patient care. We are pleased to present this Special Issue of Acta Cytologica entitled Cytopathology in Gynecology and Gynecologic Oncology: Updates, Recent Advances, and Practical Considerations, aiming to shed light on some of these issues in a concise and practical manner, to serve as an easy reference for all our cytopathology colleagues dealing with these situations in their daily practice.


中文翻译：

---

社论 - 妇科和妇科肿瘤学中的细胞病理学：更新、最新进展和实际考虑

自 50 多年前引入巴氏试验以来，细胞病理学在妇科肿瘤患者的诊断、管理和随访中的作用得到了极大的扩展。显然，HPV 检测的进步彻底改变了宫颈癌筛查，现在在 HPV 疫苗越来越多的情况下面临新的挑战。此外，最近妇科肿瘤命名法和妇科肿瘤分期的变化带来了细胞病理学特有的挑战，如果不考虑这些挑战，可能会导致不正确的诊断、患者及其临床团队的混淆，以及潜在的次优患者关心。我们很高兴向您介绍本期 Acta Cytologica 特刊，题为妇科和妇科肿瘤学中的细胞病理学：更新、最新进展、